Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 1 results out of 1
Data Insights
KB-408 by Krystal Biotech for Alpha-1 Antitrypsin Deficiency (A1AD): Likelihood of Approval
KB-408 is under clinical development by Krystal Biotech and currently in Phase I for Alpha-1 Antitrypsin Deficiency (A1AD). According to...